Importantly, muscle cells appear to be less sensitive than breast cancer cells to DOX-mediated cytotoxicity when administered in conjunction with magnetic exposure (Figure 5), possibly reflecting inherently lower expression levels of TRPC1 in healthy muscle. This evidence concerns the gene TRPC1 and breast carcinoma.